Background. In the present longitudinal study, we attempted to identify the determinants of cardiorenal damage progression in normotensive subjects (<140/90 mm Hg) and patients with never-treated essential hypertension.
presence of hypertension at baseline enhanced the yearly decline in creatinine clearance [1] . In addition, it was reported that there was no decline in inulin clearance within a follow-up period of 14 in normotensive subjects, whereas a consistent fall was observed in treated patients with essential hypertension [6] . In recent cross-sectional studies, it was found that impaired glucose tolerance [7] , as well as the presence of left ventricular concentric remodeling or hypertrophy [5] were associated with an increase in the slope of the inverse relationship between age and GFR in subjects with never-treated essential hypertension.
In the present longitudinal study conducted in a population of normotensive and never-treated individuals with essential hypertension and within a follow-up period of 3 to 13 years, we assessed the evolution as well as the determinants of changes in arterial pressure, GFR, renal hemodynamics, and cardiac geometry.
METHODS

Study population
The study population consisted in 30 normotensive subjects (12 women and 18 men, aged 14 to 72 years) and 33 hypertensive subjects (12 women and 21 men, aged 16 to 62 years), including medical students, hospital employees, or subjects recruited from the outpatient clinic of the department of medicine, where individuals came for global health evaluation. Normotension was defined as arterial pressure <140/90 mm Hg on at least two subsequent visits. None of the subjects had ever received antihypertensive therapy. Patients with clinical evidence of atherosclerosis (stroke, coronary, and peripheral artery disease), heart failure, renal failure (serum creatinine >120 lmol/L), diabetes mellitus (fasting blood glucose >6.7 mmol/L), marked obesity [body mass index (BMI) ≥35 kg/m 2 ], or a history of alcohol abuse (>5 drinks/day) were excluded. Doppler echocardiography was used to detect valvular lesions in all patients.
Subjects were evaluated at baseline and after a median follow-up period of 5.2 years (range 3 to 13 years). For various reasons, none of the patients included in the present study received antihypertensive therapy during the follow-up period. In fact, all hypertensive patients had voluntarily discontinued our prescribed antihypertensive agents within 6 months after initiation.
Blood pressure measurements
Arterial pressure was measured every 3 minutes with an automatic device (Model 8800) (Colin Corp., Komaki-City, Japan) [8] and reported values are the average of at least ten measurements following a 10-minute period of rest in the supine position. Hypertension was defined as systolic arterial blood pressure ≥140 mm Hg or diastolic arterial blood pressure ≥90 mm Hg. Normotensive patients were classified as optimal (systolic blood pressure of less than 120 mm Hg and diastolic blood pressure of less than 80 mm Hg), normal (systolic blood pressure of 120 to 129 mm Hg or diastolic blood pressure of 80 to 84 mm Hg), or high-normal blood pressure (systolic blood pressure of 130 to 139 mm Hg or diastolic blood pressure of 85 to 89 mm Hg). If the systolic and diastolic blood pressure readings belonged to different categories, the higher of the two readings was used to assign to a blood pressure category [9] .
Determination of renal function
Patients came to the ward with two consecutive 24hour urine collections for the determination of sodium (as an index of sodium intake), potassium, urea, creatinine, and albumin excretion [urinary albumin excretion (UAE) measured by radioimmunoassay]. To avoid interference with the assessment of renal function, patients were requested to stop any nonsteroidal anti-inflammatory drugs or cimetidine at least 1 week before the procedure. As previously described [10] , GFR and ERPF were estimated by urinary clearances of technetium-labeled diethylene triaminopentaacetic acid (99mTc-DTPA) and 131I-ortho iodohippurate, respectively, using the constant infusion technique and three to four timed urine collections obtained every 30 minutes by spontaneous voiding. Blood samples were obtained prior to clearance determination for the measurement of plasma renin activity and aldosterone concentration (radioimmunoassay) (CEA Sorin Kit) (France, Saclay). Measured creatinine clearance using 24-hour urine collection, GFR and ERPF were normalized for a body surface area of 1.73 m 2 . Filtration fraction was calculated as GFR/ERPF. The reproducibility of day-to-day measurements of GFR and ERPF obtained in 20 subjects and expressed as coefficient of variation was 6.4% and 6.3%, respectively.
Echocardiography
Echocardiographic assessment of left ventricular morphology was performed by the same observer with an Acuson 128 XP10 (Acuson, Mountain View, CA, USA) with 2.5 or 3.5 MHz transducer. Technical details were reported elsewhere [11] . Left ventricular hypertrophy (LVH) was defined as left ventricular mass index (LVMI) greater than 110 g/m 2 in females and 127 g/m 2 in males. Of note, these cutoff values were obtained in a previous local sample of normal subjects with blood pressure <140/90 mm Hg [11] . Concentric and eccentric LVH were defined by the existence of increased (≥0.44) or normal relative wall thickness (RWT), respectively. Concentric remodeling was defined by the finding of normal left ventricular mass associated with increased RWT.
Statistical analysis
SPSS for Windows, version 11.0 software (SPSS Inc., Chicago, IL, USA) was used for statistical analysis. Differences in continuous variables between two groups were assessed by the Student t test for parametric data and differences in categorical data were assessed by the chi-square analysis. Due to skewed distribution, urinary albumin (lg/min or mg/mmol creatinine), plasma renin activity, and plasma aldosterone were log transformed prior to comparison of groups. The primary outcome parameters of interest were yearly changes in systolic blood pressure, GFR, ERPF, albuminuria, and LVMI. Relationships between outcome parameters and potential predictors were first examined through linear univariate regression analysis. The following prespecified independent baseline variables were included in all models: gender, age, BMI, smoking, serum creatinine and uric acid, cholesterol and triglycerides, GFR, ERPF, urinary urea, sodium and albumin excretion, plasma aldosterone and renin activity, LVMI, RWT, and blood pressure (systolic, diastolic, mean, and pulse). Change in blood pressure during follow-up was also tested as a predictor of changes in GFR, ERPF, albuminuria, and LVMI. Variables that exhibited significant univariate correlation with outcome parameters were then included in a multiple stepwise regression analysis. To avoid the regression to the mean phenomenon, baseline value of renal or cardiac parameters were always included in the multivariate model. Because gender is a determinant of left ventricular mass, gender was included in the multivariate analysis on left ventricular mass progression. Two-tailed (P < 0.05) was considered statistically significant. Results are expressed as mean ± SD or median (range).
RESULTS
Baseline characteristics
In "normotensive" individuals, the proportion of subjects with optimal, normal and high-normal blood pressure as defined by the World Health Organization (WHO) [9] were respectively 10%, 33%, and 57%. At baseline, age, gender, BMI, smoking, serum creatinine, lipid profile, fasting blood glucose, and natriuresis were similar in normotensive and hypertensive subjects ( Table 1 ). As shown in Table 2 , measured creatinine clearance, GFR, and ERPF were similar in both groups. Filtration fraction was higher in hypertensive than normotensive subjects. UAE was slightly but significantly higher in hypertensive as compared to normotensive subjects; in the 33 hypertensive patients, six had UAE between 10 and 20 lg/min and five patients had UAE higher than 20 lg/min (i.e., within the microalbuminuric range). LVMI and RWT were higher in hypertensive than normotensive subjects; and in the hypertensive group, normal geometry was found in 35%, concentric remodeling in 26%, concentric hypertrophy in 17%, and eccentric hypertrophy in 22%.
Progression of blood pressure
As depicted in Table 3 , the mean yearly progression of blood pressure was 2.4 ± 3.7 for the systolic and 0.9 ± 1.7 mm Hg/year for the diastolic blood pressure in normotensive subjects. Among the 15/30 normotensive sub-jects who became hypertensive during follow-up, one had optimal, two had normal, and 12 had high-normal blood pressure at baseline. In fact, 71% of subjects with highnormal blood pressure at baseline progressed to clinical hypertension. Interestingly, 10 of these 15 subjects developed isolated systolic hypertension (systolic blood pressure ≥140 mm Hg and diastolic blood pressure <90 mm Hg).
In subjects who were hypertensive at baseline, the yearly progression of blood pressure was 1.9 ± 3.2 for the systolic and 0.5 ± 2.0 mm Hg/year for the diastolic blood pressure; and the change in blood pressure was similar in female and male subjects. No change in natriuresis and BMI was observed at follow-up examination.
In the whole population, systolic blood pressure progression was directly correlated with age and the baseline level of cholesterol and triglyceride and inversely correlated with the baseline value of GFR. No relationship with basal natriuresis and BMI was found. However, in multiple regression analysis, only age remained directly correlated with the progression of systolic blood pressure, independently of the systolic blood pressure at baseline (model r 2 = 0.17) (P < 0.005) ( Table 4 ). 
Progression of renal function and hemodynamics
As shown in Table 3 , the decline of GFR during followup was more marked in hypertensive than normotensive subjects (−1.22 ± 2.71 vs. 0.12 ± 2.08 mL/min/1.73 m 2 /year) (P = 0.033). In univariate regression analysis conducted in the whole population, the yearly change in GFR was inversely correlated with basal values of systolic, mean and pulse pressure; UAE (log transformed) and RWT. In fact, the higher the basal value of blood pressure, UAE, and RWT, the higher the magnitude of the decrease of GFR with time. In multivariate regression analysis, the yearly change in GFR remained correlated with the basal value of systolic blood pressure, but not UAE or RWT, independently of the basal value of GFR (model r 2 = 0.44) (P < 0.0001).
In univariate analysis, the yearly change in ERPF was inversely correlated with the baseline values of systolic blood pressure, UAE, and LVMI and the yearly change in mean blood pressure. In multivariate analysis, the yearly change in ERPF remained correlated with the baseline value of UAE and the yearly change in mean blood pressure during follow-up, independently of the basal value of ERPF (model r 2 = 0.22) (P < 0.005) ( Table 4 ). Of interest, expression of GFR and ERPF per meter of height, in order to unmask the influence of obesity [12] , yielded similar observations.
Progression of albuminuria
During follow-up, new onset microalbuminuria (UAE ≥20 lg/min) was observed in one normotensive subject who converted to hypertension during follow-up and in three subjects who were hypertensive at baseline. In univariate analysis, progression of UAE was directly correlated with the yearly change in blood pressure and baseline values of cholesterol and triglycerides. However, the change in UAE was correlated with the change in blood pressure in subjects who were hypertensive but not in those who were normotensive at baseline. In multivariate analysis, the yearly change in UAE was independently correlated with the yearly change in mean blood pressure and the basal value of triglycerides (model r 2 = 0.27) (P < 0.001).
Progression of cardiac morphology
As shown in Table 3 , LVMI increased during follow-up in the whole population; however, the increase tended to be more sustained in men (3.14 ± 3.93 g/m 2 /year) as compared to women (1.16 ± 2.74 g/m 2 /year). No difference in LVMI progression between normotensive and hypertensive groups was observed. The yearly increase in LVMI was directly correlated with the yearly change in blood pressure and basal values of plasma aldosterone, uric acid, and triglyceride concentration, and inversely correlated with the baseline value of high-density lipoprotein (HDL) cholesterol. In multivariate analysis, LVMI progression remained correlated with baseline values of plasma aldosterone, uric acid, and triglycerides and the yearly change in systolic but not diastolic blood pressure, independently of basal LVMI (model r 2 = 0.71) (P < 0.0001) ( Table 4 ).
DISCUSSION
In the present longitudinal study conducted in 63 normotensive and hypertensive subjects followed during a median period of 5.2 years (range 3 to 13 years), the baseline value and/or the progression of blood pressure during follow-up were the main determinants of the increase in LVMI, the deterioration of renal function and the increase in albuminuria.
As previously reported in the Framingham Heart Study [13] , it was found that a rather large proportion (71%) of subjects with high-normal blood pressure at baseline progressed to hypertension during follow-up. Similarly, in a recent study conducted in a group of 162 normotensive and hypertensive healthy adults aged 55 to 79 years, 62% of patients with high-normal blood pressure at baseline converted to hypertension within a follow-up period of 5 years [14] . In contrast with the later study, baseline blood pressure was not a strong determinant of blood pressure progression in the present study; and age emerged as the most powerful factor of the increase in blood pressure with time.
Although blood pressure progression was inversely correlated with baseline GFR (the lower the value of baseline GFR the higher the increase in blood pressure), its influence did not remain when adjustment for age was made, probably due to the strong relationship between age and GFR. Interestingly, in a group of 33 normoalbuminuric normotensive subjects with type 1 diabetes, final mean blood pressure was associated with age and GFR at baseline, within a follow-up period of 8.4 years [15] .
In the present study, GFR decreased by 0.58 mL/ min/1.73 m 2 /year in the whole population; however, this decrease was significant only in subjects with hypertension at baseline (−1.22 vs. 0.12 mL/min/1.73 m 2 /year). Thus hypertension tends to accelerate the fall of GFR associated with aging. This is in perfect agreement with other longitudinal studies conducted in untreated subjects and using creatinine clearance as a marker of renal function [1] . No change in GFR (inulin clearance) was observed within a follow-up period of 14 years in normotensive individuals, whereas a significant decline was observed in hypertensive subjects adequately controlled by drug therapy [6] . In fact, in the Multiple Risk Factor Intervention Trial (MRFIT), progression to end-stage renal disease (ESRD) within a follow-up period of 16 years was observed in 0.67% of subjects with systolic blood pressure between 160 and 179 mm Hg, 0.18% of subjects with high-normal blood pressure and 0.08% of subjects with optimal blood pressure at baseline [16] .
Although the observed decrease in GFR was significantly influenced by baseline systolic blood pressure, RWT of the left ventricle and albuminuria in univariate analysis, the change in GFR was only influenced by baseline systolic blood pressure independently of baseline GFR in multivariate analysis. In a recent cross-sectional study conducted in 645 never-treated hypertensive subjects, it was reported that the age-associated decline of GFR was enhanced by the concentric pattern of left ventricular geometry [5] . In contrast to diabetes [17] , no influence of albuminuria on the progression of GFR was observed. Nevertheless, only one study has emphasized the relationship between baseline UAE and the change in creatinine clearance in essential hypertensive subjects treated for 7 years [18] .
Although ERPF did not change significantly during follow-up in the whole population, multivariate analysis revealed that baseline UAE and change in mean blood pressure remained inversely correlated with the change in ERPF, independently of baseline ERPF. This suggests that renal vasoconstriction progressively developed in subjects with high UAE at baseline and the largest increase in blood pressure during follow-up.
The change in mean blood pressure and baseline triglyceride emerged as the strongest independent determinants of the change in UAE. Several studies conducted in patients with essential hypertension have shown that the change in UAE was highly correlated with the change in blood pressure [19, 20] . Nevertheless, in the present study, the influence of the change in blood pressure on the change in UAE was present only in subjects with hypertension at baseline. This is in agreement with our recent report that within the "normotensive" range (<140/ 90 mm Hg), no correlation between blood pressure and UAE was observed, in contrast with the exquisite sensitivity of LVMI to blood pressure [21] .
A significant increase in LVMI was presently observed in normotensive and hypertensive subjects, in the absence of change in sodium intake [11] and BMI. However, despite a similar change in blood pressure, LVMI increased during follow-up only in male subjects, thus supporting our finding that within the "normotensive" range, LVMI correlates with blood pressure more strongly in men than women [21] .
Among the determinants of the change of LVMI during follow-up were baseline values of plasma aldosterone and serum uric acid, in addition to the change in systolic blood pressure. In fact, 71% of the variance of LVMI progression was explained by these three parameters. Although a high initial aldosterone may predispose to an important increase in LVMI in response to the rise in systemic blood pressure, the role of aldosterone remains unclear. In fact, a few studies have recently emphasized the favorable effects of mineralocorticoid receptor blockade by spirolonolactone on LVMI, in the absence of change in blood pressure, in hypertensive patients treated by angiotensin-converting enzyme (ACE) inhibitors [22] .
In the present longitudinal study, it was demonstrated that within a follow-up period of 3 to 13 years, the change in blood pressure was solely dependent on age, whereas changes in GFR, UAE, and LVMI were almost exclusively predicted by basal or change in blood pressure, thus emphasizing the crucial role of blood pressure in cardiorenal changes. 
